Tag: Drug Manufacturing

Eli Lilly to Invest $400m in Indianapolis Manufacturing Facilities

Eli Lilly and Company announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis. The plans are driven by increasing demand for Lilly'...

Samsung Biologics Agreed with Ichnos Sciences on ISB 830 Manufacturing

samsung biologics
Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treat...

GSK to Invest $120m in Manufacturing Facility Expansion

gsk
GSK announced a $120 million investment to expand its manufacturing facility in Upper Merion, Pennsylvania that will support the delivery of the company’s pipeline, bringing new medicines for cancer a...

Pii to Manufacture Commercial Supply of Fulvestrant Injection

Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) headquartered in Hunt Valley, MD, will manufacture commercial supply of Fulvestrant Injection ...

Omega Laboratories Found Acceptable for Manufacturing FDA-Approved Products

api-manufacturing
Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals announced their Canadian subsidiary, Omega Laboratories, has been found acceptable for manufacturing FDA-approved products in its initial Establishm...

Omeros Corporation and Lonza Announced Long-term Manufacturing Agreement

lonza
Biopharma company Omeros Corporation and biotech group Lonza have announced a long-term manufacturing agreement for the commercial production of Omeros’ lead human monocloncal antibody narsoplimab...

Takeda Openes First API Manufacturing Plant outside Japan

Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland. The company CEO, government ministers and industry officials together with staff and guests ...

Grupo RPH and Telix Signed Manufacturing and Distribution Agreement

manufacturing
Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targe...

Gamida Cell and Lonza Sign Manufacturing Agreement for Omidubicel

gamida cell
Gamida Cell Ltd., a leading cellular and immune therapeutics company, and Lonza announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the fu...

Drug Production to be Launched in Moscow Special Economic Zone

drug manufacturing
An agreement clearing the pharmaceutical company R-Opra to manufacture drugs in the Technopolis Moscow special economic zone was concluded at the St. Petersburg international economic forum. Under ...

Tergus to Build Plant and Invest in Expanding Commercial Manufacturing

Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, has announced a 100,000-square-foot building for its new head...

GSK Agreed to Sell Manufacturing Site in Cork

drug manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, fro...

IQVIA Reports About the Record Number of U.S. Drugs Launched in 2018

drugs
Ongoing changes in the clinical development process led to a record number of drug approvals in 2018, with 59 novel treatments reaching patients in the United States alone. During the next five years,...

Catalent to Invest $27m for Next-Generation ODT Technology

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it is to invest mor...

AGC boosts its biopharmaceutical production capacity

biotechnology
AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

WuXi Biologics entered into partnership with AC Immune

biopharmaceutical
WuXi Biologics and AC Immune SA announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing.